Kanglaite Reverses Multidrug Resistance of HCC by Inducing Apoptosis and Cell Cycle Arrest via PI3K/AKT Pathway [Retraction]
2024 · OncoTargets and Therapy · 1 citations
https://doi.org/10.2147/ott.s463641
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
718
Citations
9
h-index
9
i10-index
Chunfeng Yu is an academic researcher. The author has contributed to research in topics: Dermatology and Skin Diseases & T-cell and B-cell Immunology & Immune Response and Inflammation. The author has an h-index of 9, co-authored 17 publications.
ORCID: 0000-0002-6329-307XClick to start Chat